These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 36558796)

  • 21. Detection of the Omicron variant of SARS-CoV-2 in international travelers returning to Venezuela.
    Jaspe RC; Sulbaran Y; Loureiro CL; Moros ZC; Marulanda E; Bracho F; Ramírez NA; Canonico Y; D'Angelo P; Rodríguez L; Castro J; Liprandi F; Rangel HR; Pujol FH
    Travel Med Infect Dis; 2022; 48():102326. PubMed ID: 35395405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
    Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
    Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
    medRxiv; 2022 Feb; ():. PubMed ID: 35169811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential viral introductions and spread of BA.1 across Pakistan provinces during the Omicron wave.
    Bukhari AR; Ashraf J; Kanji A; Rahman YA; Trovão NS; Thielen PM; Yameen M; Kanwar S; Khan W; Kabir F; Nisar MI; Merritt B; Hasan R; Spiro D; Rasmussen Z; Aamir UB; Hasan Z
    BMC Genomics; 2023 Aug; 24(1):432. PubMed ID: 37532989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological Characterization of Patients in the First Eight Weeks Following Detection of SARS-CoV-2 B.1.1.529 (omicron) Variant in Cuba.
    Pérez-Santosa L; Kourí-Cardellá V; Tejero-Suárez Y; Macías-Roig LM; Pintos-Saavedra Y; Medero-Díaz D; Figueredo-Amador C; Naranjo-González C; Morales-Arredondo D; Tamayo-Pérez NE; Martínez-Montesino Y; López-Almaguer Y; de Armas-Fernández JR; Portal-Miranda JA; Guzmán-Tirado MG
    MEDICC Rev; 2022 Oct; 24(3-4):18-23. PubMed ID: 36417330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
    Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
    Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrimination of SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Using a High-Resolution Melting-Based Assay: a Pilot Study.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    Microbiol Spectr; 2022 Aug; 10(4):e0136722. PubMed ID: 35861527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Variability in Patients and Wastewaters-Potential Immuno-Modulation during the Shift from Delta to Omicron.
    Chaqroun A; Hartard C; Josse T; Taverniers A; Jeulin H; Gantzer C; Murray JM; Obepine Consortium ; Bertrand I; Schvoerer E
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 coinfections with variant genomic lineages identified by multiplex fragment analysis.
    Lueking R; Clark AE; Narasimhan M; Mahimainathan L; Muthukumar A; Larsen CP; SoRelle JA
    Front Genet; 2022; 13():942713. PubMed ID: 36226173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction, Spread and Impact of the SARS-CoV-2 Omicron Variants BA.1 and BA.2 in Cyprus.
    Richter J; Koptides D; Tryfonos C; Alexandrou D; Christodoulou C
    Microorganisms; 2022 Aug; 10(9):. PubMed ID: 36144290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiological analysis of the first 1000 cases of SARS-CoV-2 lineage BA.1 (B.1.1.529, Omicron) compared with co-circulating Delta in Wales, UK.
    Pacchiarini N; Sawyer C; Williams C; Sutton D; Roberts C; Simkin F; King G; McClure V; Cottrell S; Clayton H; Beazer A; Williams C; Rey SM; Connor TR; Moore C
    Influenza Other Respir Viruses; 2022 Nov; 16(6):986-993. PubMed ID: 35822273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 lineage transition in the Swedish population reveals increased viral RNA levels in BA.2 cases.
    Lentini A; Pereira A; Winqvist O; Reinius B
    Med; 2022 Sep; 3(9):636-643.e4. PubMed ID: 35981541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the individual genetic evolution of SARS-CoV-2 in a small cluster during the rapid spread of the BF.5 lineage in Tokyo, Japan.
    Jin B; Oyama R; Tabe Y; Tsuchiya K; Hando T; Wakita M; Yan Y; Saita M; Takei S; Horiuchi Y; Miida T; Naito T; Takahashi K; Ogawa H
    Front Microbiol; 2023; 14():1229234. PubMed ID: 37744926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importation of SARS-CoV-2 Omicron variant in Beijing, China.
    Li F; Liang Z; Cui S; Lv B; Feng Z; Xu H; Jia L; Yang P; Wang Q; Pan Y; Zhang D
    Biosaf Health; 2022 Jun; 4(3):150-153. PubMed ID: 35463809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic Insights Into the Evolution and Demographic History of the SARS-CoV-2 Omicron Variant: Population Genomics Approach.
    Garg KM; Lamba V; Chattopadhyay B
    JMIR Bioinform Biotechnol; 2023; 4():e40673. PubMed ID: 37456139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador.
    Carrazco-Montalvo A; Herrera-Yela A; Alarcón-Vallejo D; Gutiérrez-Pallo D; Armendáriz-Castillo I; Andrade-Molina D; Muñoz-Mawyin K; Fernández-Cadena JC; Morey-León G; Usfq-Covid-Consortium ; Crn Influenza Y Ovr-Inspi ; Patiño L
    Viruses; 2022 May; 14(6):. PubMed ID: 35746651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022.
    Fonager J; Bennedbæk M; Bager P; Wohlfahrt J; Ellegaard KM; Ingham AC; Edslev SM; Stegger M; Sieber RN; Lassauniere R; Fomsgaard A; Lillebaek T; Svarrer CW; Møller FT; Møller CH; Legarth R; Sydenham TV; Steinke K; Paulsen SJ; Castruita JAS; Schneider UV; Schouw CH; Nielsen XC; Overvad M; Nielsen RT; Marvig RL; Pedersen MS; Nielsen L; Nilsson LL; Bybjerg-Grauholm J; Tarpgaard IH; Ebsen TS; Lam JUH; Gunalan V; Rasmussen M
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.